A clinical trial conducted in Thailand demonstrated moderate (31% effective) protection against acquisition of HIV infection. However, this modest degree of efficacy does not justify deployment of the vaccine; active investigation continues in the pursuit of a safe and effective vaccine against HIV, including focusing on the induction of broadly neutralizing antibodies to HIV.
Section 7. Infectious Diseases